Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 23, 2025 • 11:31 PM ET

Date/Time Source News Release
04/09/2025 08:30 AM EDT PR Newswire NeuroSense Therapeutics Announces Transformative Phase 2b MicroRNA Data, Highlighting PrimeC's Promise as a Disease-Modifying ALS Treatment
04/07/2025 05:14 PM EDT PR Newswire NeuroSense Therapeutics Reports Year End 2024 Financial Results and Provides Business Updates
04/04/2025 09:10 AM EDT PR Newswire NeuroSense Therapeutics to Present New Data from PrimeC's Phase 2b Trial in ALS at the Annual American Academy of Neurology Meeting
03/20/2025 10:30 AM EDT Business Wire Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
03/17/2025 08:30 AM EDT Business Wire PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
01/06/2025 09:00 AM EST PR Newswire NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement
12/23/2024 09:00 AM EST PR Newswire NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS
12/18/2024 10:25 AM EST PR Newswire NeuroSense Provides Business Update and Third Quarter 2024 Financial Results
12/11/2024 09:25 AM EST PR Newswire NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC
12/04/2024 08:30 AM EST PR Newswire NeuroSense Announces Completion of PARADIGM Study Highlighting PrimeC's Significant Efficacy and Survival Benefits in ALS
Page

Additional News

As of April 23, 2025 • 11:31 PM ET

Date/Time Source News Release
04/08/2025 03:45 AM EDT SeekingAlpha NeuroSense Therapeutics GAAP EPS of -$0.54
04/04/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, April 4th, 2025
04/04/2025 05:30 AM EDT US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
04/03/2025 06:49 PM EDT KlickAnalytics NRSN - Historical Price Movements Surrounding Earnings
04/03/2025 06:44 PM EDT KlickAnalytics NRSN - Historical Earnings Price Analysis
12/26/2024 04:56 PM EST SeekingAlpha NeuroSense Therapeutics files to sell 5.28M ordinary shares for holders
12/17/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, December 17th, 2024
12/17/2024 04:31 AM EST US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
12/10/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, December 10th, 2024
12/10/2024 04:30 AM EST US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.